Cardiomyopathic Hamsters, CHF 146 and CHF 147: a Preliminary Study

Overview

Journal Can J Physiol Pharmacol

Specialties Pharmacology
Physiology

Date 1984 Nov 1

PMID 6509387

Citations 13

Authors

E G Hunter

V Hughes

J White

Affiliations

Soon will be listed here.

Abstract

The time course and characteristics of lesion development in both cardiac and skeletal muscle from two strains of cardiomyopathic hamsters (CHF 146 and CHF 147) were studied by histological methods. The chronology of lesion development and the histological characteristics of the lesions were similar in both strains. However, increased calcification of cardiac lesions was present in the hearts of CHF 147 animals. This may account for the difference in lifespan between the CHF 147 (350 days) and the CHF 146 (440 days).

Citing Articles

Retrospective Study of Intercalated Disk Defects Associated with Dilated Cardiomyopathy, Atrial Thrombosis, and Heart Failure in BALB/c Mice Deficient in IL4 Receptor α.

Gozalo A, Zerfas P, Elkins W, Gieseck R Comp Med. 2020; 70(3):266-276.

PMID: 32384942 PMC: 7287387. DOI: 10.30802/AALAS-CM-19-000059.

SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.

Bouyon S, Roussel V, Fromes Y Hum Gene Ther. 2014; 25(8):694-704.

PMID: 24645914 PMC: 4137356. DOI: 10.1089/hum.2013.132.

Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters.

Wu R, Yin D, Sadekova N, Deschepper C, de Champlain J, Girouard H Oxid Med Cell Longev. 2012; 2012:761710.

PMID: 22829962 PMC: 3399583. DOI: 10.1155/2012/761710.

Rodent models of heart failure: an updated review.

Gomes A, Falcao-Pires I, Pires A, Bras-Silva C, Leite-Moreira A Heart Fail Rev. 2012; 18(2):219-49.

PMID: 22446984 DOI: 10.1007/s10741-012-9305-3.

δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Blain A, Straub V Skelet Muscle. 2011; 1(1):13.

PMID: 21798091 PMC: 3156636. DOI: 10.1186/2044-5040-1-13.